Tumor/stromal interactions via growth factor signaling

Anton Wellstein

Dr Wellstein's laboratory studies tumor/stromal interactions via growth factor signaling. In invasiveĀ prostate cancerĀ the survival receptor ALK is highly upregulated and blocking this pathway using mAbs will be one of the fields of study. Also, circulating markers of a switch from in-situ to invasive prostate cancer are under investigation for risk and prognostic analyses.